NeoProteomics is a large-scale study formed on the heels of The Human Genome Project. It provides research services and tools for human disease detection and diagnosis, specifically cancer. The company focuses on accelerating the process of drug and diagnostics development by providing innovative analysis tools to help its clients understand genomics and proteomics data at the systems level.
“Freeport Metrics was able to provide a reliable and professional team for our projects, and they quickly grasped the scientific concepts that are part of our core algorithms. They have proven to be valuable partner.”
Jr. President & CEO of NeoProteomics